Drugplain

ELIGARD

Leuprolide Acetate · KIT · TOLMAR Inc.

No Recall History
Plain English

Eligard is a prescription injection containing leuprolide acetate, a medication used to treat advanced prostate cancer and endometriosis by reducing hormone levels in the body. It is administered as a subcutaneous injection under the skin.

Key Facts

Brand Name
ELIGARD
Generic Name
Leuprolide Acetate
NDC Code (Product)
62935-753
Manufacturer
TOLMAR Inc.
Dosage Form
KIT
Route
SUBCUTANEOUS
Marketing Status
Application #
NDA021343
Marketing Start
05/15/2002

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

intercepted product preparation error8,869 reports
syringe issue7,730 reports
hot flush6,264 reports
death6,260 reports
device leakage5,988 reports
wrong technique in product usage process5,213 reports
injection site pain4,198 reports
fatigue3,463 reports
prostatic specific antigen increased1,924 reports
intentional product use issue1,647 reports

Frequently Asked Questions

What is ELIGARD used for?

Eligard is a prescription injection containing leuprolide acetate, a medication used to treat advanced prostate cancer and endometriosis by reducing hormone levels in the body. It is administered as a subcutaneous injection under the skin.

Is ELIGARD a controlled substance?

ELIGARD is not classified as a controlled substance by the DEA.

What is the generic name for ELIGARD?

The generic name for ELIGARD is Leuprolide Acetate. There are 11 other brand versions of Leuprolide Acetate.

What is the NDC code for ELIGARD ?

The NDC (National Drug Code) for ELIGARD is 62935-753, listed by TOLMAR Inc..